Dr. Martin is an internationally recognized developmental and regenerative biologist who has made fundamental contributions to our understanding of development, disease, and regeneration. He has authored more than 135 peer-reviewed papers in top journals such as Nature, Science, Cell, Developmental Cell, Plos Genetics, Development, and PNAS. Show full bio
Dr. Martin’s research is aimed at understanding how signaling pathways are related to development and tissue regeneration. The ultimate goal of his work is to obtain an in depth understanding of these pathways in order to develop ways to treat congenital diseases and regenerate heart muscle and other adult tissues.
Heart failure is a leading cause of death because heart muscle is non-regenerative. Dr. Martin has helped solve the problem of failed heart muscle regeneration by discovering the important pathways that inhibit heart muscle regeneration. He has shown that adult heart muscle can be molecularly manipulated to promote heart repair.
He and his team recently discovered that Hippo signaling is a critical repressor of adult heart regeneration. His lab has worked with single cell transcriptomics for the past three years and has developed the expertise to perform and analyze data. This recent groundbreaking work on the Hippo pathway in heart size regulation is a landmark study that led to the insight that the Hippo pathway is an inhibitor of adult heart muscle regeneration. Dr. Martin’s insights revealed new avenues for treatment of human heart failure.
Dr. Martin has also made fundamental insights into the role of the transcription factor Pitx2 in atrial fibrillation, the most common sustained arrhythmia in the human population. He made use of the mouse model to investigate Pitx2 in atrial homeostasis but also in left right asymmetric morphogenesis that is essential for human development. Dr. Martin’s studies investigating Pitx2 function in craniofacial development provided insight into the molecular basis of Rieger syndrome. He uncovered a pivotal function for Bmp signaling in endothelial-mesenchymal transition and cardiac valve development. Dr. Martin’s studies uncovered a novel role for canonical Wnt signaling in cardiac progenitor cell diversification. He found the first microRNA implicated in orofacial clefting. Dr. Martin’s studies are highly cited and also reported on by the lay media.
Texas Heart Institute Positions
- Director, Cardiomyocyte Renewal Laboratory
- Genetic pathways & cell signaling
- microRNAs in development and disease
- Bmp signaling in development and human disease
- Pitx2 in cardiovascular development and disease
- Wnt and Hippo signaling in heart development and regeneration
- Cardiac and craniofacial stem cell biology
- Cell and Developmental Biology
- Molecular Biology and Genetics
- Human Disease
- Cardiovascular Sciences
Fordham University (Bronx, NY)
University of Texas Medical School At Houston
The University of Texas Health Science Center, GSBS, Houston, TX
University of Texas MD Anderson Cancer Center
Academic & Clinical Affiliations
- Baylor College of Medicine
- Faculty Member, The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences
- Faculty Member, The Texas A&M System Health Science Center, Graduate School of Biomedical Sciences, College Station, Texas
- Texas State Board of Medical Examiners
Honors, Awards and Memberships
- American Heart Association
- Heart Rhythm Society
- Society for Developmental Biology
- Texas Heart Institute Professional Staff
- Vivian Smith Professor in Regenerative Medicine;
Houston Chronicle Features Dr. Jim Martin’s ground breaking research aimed to change how we treat heart failure
Patients suffering from heart failure have very limited treatment options, and up to this point, it had essentially been impossible...
Groundbreaking Cardiovascular Gene Therapy Has Potential to Drastically Alter Outlook for Heart Failure Patients
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
Heart failure impacts 26 million people around the world and remains one of the most devastating heart conditions today. Our...